NASDAQ:CLVS
Delisted
Clovis Oncology Stock News
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Bet on 5 Top Stocks With Rising P/E
02:39pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Forget undervalued stocks, play top-ranked stocks like Clovis Oncology (CLVS), NiSource (NI), DocuSign (DOCU), Root (ROOT) and Endava (DAVA).
Bet on 5 Top Stocks With Rising P/E
11:17am, Wednesday, 21'st Dec 2022
Forget undervalued stocks, play top-ranked stocks like Clovis Oncology (CLVS), NiSource (NI), DocuSign (DOCU), Root (ROOT) and Endava (DAVA).
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
11:30am, Wednesday, 14'th Dec 2022 Benzinga
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Crown ElectroKinetic
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
05:14pm, Tuesday, 13'th Dec 2022 Benzinga
Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Netcapital Inc. (NASDAQ: NCPL
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
03:38pm, Monday, 12'th Dec 2022 Zacks Investment Research
Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pipeline candidates.
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
02:05pm, Monday, 12'th Dec 2022
Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed selling a separate therapy to a Novartis affiliate.
Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid
12:02pm, Monday, 12'th Dec 2022
Recent regulatory developments force Clovis (CLVS) to file for bankruptcy. The company inks a stalking horse agreement with Novartis for one of its pipeline candidates.
CLVS Stock Alert: What to Know as Clovis Oncology Files for Bankruptcy
10:26am, Monday, 12'th Dec 2022
Clovis Oncology (NASDAQ: CLVS ) stock is on the move Monday as investors react to the pharmaceutical company filing for bankruptcy protection. The first thing that investors need to know about is Clov
Clovis Oncology stock slides 10% premarket after company files for bankruptcy
06:37am, Monday, 12'th Dec 2022
Clovis Oncology Inc. stock CLVS, -9.94% fell 10% in premarket trade Monday, after the biotech filed for Chapter 11 bankruptcy and said it would sell assets. The company has a commitment for up to $75
Clovis (CLVS) Down 18.1% Since Last Earnings Report: Can It Rebound?
04:30pm, Friday, 09'th Dec 2022 Zacks Investment Research
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Top Ships Shares Are Trading Lower By Over 60%; Here Are 24 Stocks Moving Premarket
01:16pm, Monday, 05'th Dec 2022 Benzinga
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 18.1% to $0.6316 in pre-market trading after jumping over 34% on Friday. Cosmos Holdings, last month, posted Q3 loss of $0.08 per share.
Zhihu
Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
12:44pm, Monday, 05'th Dec 2022
Investors in Clovis Oncology (NASDAQ: CLVS ) stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company. According to a filing with the U.S. Securities and
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
05:34pm, Friday, 25'th Nov 2022 Zacks Investment Research
Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
02:18pm, Friday, 25'th Nov 2022
Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.
Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)
02:35pm, Monday, 21'st Nov 2022 Zacks Investment Research
Clovis (CLVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea
